Acurx Pharmaceuticals, Inc.

ACXP - Company ID 0001736243

Market cap-

Rank-

Filings232

Acurx Pharmaceuticals, Inc. has filed 232 public company documents between 2018 and 2026. The most frequent type is insider trade (51 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchACXP overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut ACXP beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow ACXP via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
S-3/A	S-3/A	6mo ago2025-12-30	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	7mo ago2025-11-14	-	View filing
10-Q	Quarterly report	8mo ago2025-11-12	2025-09-30	View filing
424B3	424B3	8mo ago2025-11-10	-	View filing
S-1	IPO registration	8mo ago2025-10-20	-	View filing
8-K	Major company event	9mo ago2025-09-22	2025-09-22	View filing
8-K	Major company event	9mo ago2025-09-19	2025-09-16	View filing
SCHEDULE 13G	SCHEDULE 13G	11mo ago2025-08-14	-	View filing
10-Q	Quarterly report	11mo ago2025-08-11	2025-06-30	View filing
DEFA14A	Proxy materials	11mo ago2025-08-05	-	View filing
DEF 14A	Proxy statement	11mo ago2025-08-04	2025-09-16	View filing
8-K	Major company event	11mo ago2025-07-31	2025-07-31	View filing
PRE 14A	PRE 14A	11mo ago2025-07-24	2025-09-16	View filing
EFFECT	EFFECT	11mo ago2025-07-23	-	View filing
CORRESP	Company correspondence	11mo ago2025-07-21	-	View filing
UPLOAD	SEC correspondence	11mo ago2025-07-21	-	View filing
8-K	Major company event	11mo ago2025-07-17	2025-07-17	View filing
S-1	IPO registration	12mo ago2025-07-15	-	View filing
UPLOAD	SEC correspondence	12mo ago2025-07-14	-	View filing
S-3	Securities registration	1y ago2025-07-09	-	View filing
D	D	1y ago2025-06-27	-	View filing
8-K	Major company event	1y ago2025-06-20	2025-06-17	View filing
EFFECT	EFFECT	1y ago2025-05-29	-	View filing
424B3	424B3	1y ago2025-05-29	-	View filing
ARS	Annual report to shareholders	1y ago2025-05-29	2024-12-31	View filing
DEFA14A	Proxy materials	1y ago2025-05-29	-	View filing
DEF 14A	Proxy statement	1y ago2025-05-29	2025-07-17	View filing
CORRESP	Company correspondence	1y ago2025-05-27	-	View filing
UPLOAD	SEC correspondence	1y ago2025-05-27	-	View filing
S-1	IPO registration	1y ago2025-05-21	-	View filing
D	D	1y ago2025-05-20	-	View filing
PRE 14A	PRE 14A	1y ago2025-05-19	2025-07-17	View filing
8-K	Major company event	1y ago2025-05-13	2025-05-13	View filing
10-Q	Quarterly report	1y ago2025-05-12	2025-03-31	View filing
8-K	Major company event	1y ago2025-05-08	2025-05-08	View filing
EFFECT	EFFECT	1y ago2025-04-14	-	View filing
CORRESP	Company correspondence	1y ago2025-04-10	-	View filing
UPLOAD	SEC correspondence	1y ago2025-04-10	-	View filing
S-1	IPO registration	1y ago2025-04-04	-	View filing
8-K	Major company event	1y ago2025-03-28	2025-03-25	View filing
D	D	1y ago2025-03-21	-	View filing
EFFECT	EFFECT	1y ago2025-03-19	-	View filing
8-K	Major company event	1y ago2025-03-18	2025-03-18	View filing
10-K	Annual report	1y ago2025-03-17	2024-12-31	View filing
S-8	Employee stock plan	1y ago2025-03-17	-	View filing
POS AM	POS AM	1y ago2025-03-17	-	View filing
8-K	Major company event	1y ago2025-03-10	2025-03-06	View filing
424B5	Prospectus supplement	1y ago2025-03-10	-	View filing
8-K	Major company event	1y ago2025-02-26	2025-02-24	View filing
EFFECT	EFFECT	1y ago2025-02-06	-	View filing

Acurx Pharmaceuticals, Inc.

Similar companies to research next

Year